News
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
For Dr Alexandra Sowa, author of ‘The Ozempic Revolution’, getting onto GLP-1 drugs like Mounjaro or Ozempic is not a ...
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Aesthetic Obsession: A dive into the rising fixation with weight loss drugs and cosmetic quick fixes
If fillers are about retaining youth, Ozempic is about nailing the metabolism — with needles doing the heavy lifting ...
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss ...
"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results